期刊文献+

炎症性肠病患者血清纤维化指标的变化 被引量:1

Alterations of Serum Fibrotic Markers in Patients with Inflammatory Bowel Disease
暂未订购
导出
摘要 背景:炎症性肠病(IBD)具有慢性和反复发作的特点,肠壁组织反复损伤和修复可致局部纤维化和瘢痕形成。目的:观察IBD患者常用血清纤维化指标层黏蛋白(LN)、Ⅳ型胶原(C-Ⅳ)、透明质酸(HA)和Ⅲ型前胶原氨基端肽(PⅢNP)的变化,评价其与疾病活动度的关系。方法:收集经结肠镜和活检病理检查确诊的48例溃疡性结肠炎(UC)患者、50例克罗恩病(CD)患者和50例对照者,以放射免疫测定检测血清LN、C-Ⅳ、HA和PⅢNP水平,以酶联免疫吸附测定(ELISA)检测血清高敏C反应蛋白(hs-CRP)水平。结果:与对照组相比,UC和CD患者血清LN水平显著增高,C-Ⅳ和PⅢNP水平显著降低(P<0.05),UC和CD两组间则无明显差异;三组间血清HA水平均无明显差异。血清hs-CRP水平可反映IBD疾病活动度,活动期患者hs-CRP水平均高于200mg/L。IBD患者的LN水平与hs-CRP呈正相关(UC:r=0.33,CD:r=0.53.P<0.05),C-Ⅳ和PⅢNP水平与hs-CRP无明显关联。LN水平与CD病变部位无明显关联。结论:IBD患者血清LN水平增高,C-Ⅳ和PⅢNP水平降低,可能成为肠壁组织炎症和修复的间接标志物:血清LN水平可间接反映IBD疾病活动度。 Background: Chronic and recurrent inflammation is the main characteristic of inflammatory bowel disease (IBD), and repeated injury and repair of the intestinal wall may result in local fibrosis and scar formation. Aims: To study the alterations of commonly used serumfibrotic markers, laminin (LN), collagen Ⅳ (C-Ⅳ), hyaluronic acid (HA) and procollagen m N-terminal peptide (PmNP) in IBD patients and the correlations between these markers and the activity of disease. Methods: Forty-eight ulcerative colitis (UC), 50 Crohn's disease (CD) diagnosed by colonoscopy and biopsy pathology and 50 matched controls were recruited in this study. The serum levels of LN, C-Ⅳ, HA and PmNP were measured by radioimmunoassay, and serum level of high-sensitivity C-reactive protein (hs-CRP) by enzyme-linked immunosorbent assay (ELISA). Results: In UC and CD patients, the serum level of LN was significantly higher and the serum levels of C-Ⅳ and pIIlNP were signifieandy lower than those in the controls (P〈0.05), while the serum level of HA was not different from that in the controls. No difference was found between UC and CD patients for all these markers. Serum level of hs-CRP could reflect the disease activity of IBD, and the serum level of hs-CRP in active patients were higher than 200 mg/L. There was a positive correlation between serum levels of LN and hs-CRP in IBD patients (UC: r= 0.33, CD: r=0.53, P〈0.05), but not between C-Ⅳ and hs-CPR as well as Pm NP and hs-CRP. No association was found between serum LN level and disease location in CD. Conclusions: The increased serum level of LN as well as decreased serum levels of C-Ⅳ and P m NP may be used as indirect markers for sustained intestinal wall inflammation and tissue repairing in IBD patients. Serum level of LN may reflect the disease activity of IBD indirectly.
出处 《胃肠病学》 2007年第10期623-625,共3页 Chinese Journal of Gastroenterology
关键词 炎性肠疾病 层黏连蛋白 胶原Ⅳ型 透明质酸 前胶原 C反应蛋白 Inflammatory Bowel Diseases Laminin Collagen Type Ⅳ Hyaluronic Acid Procollagen C-Reactive Protein
  • 相关文献

参考文献8

  • 1欧阳钦.炎症性肠病研究中值得注意的几个问题[J].胃肠病学,2001,6(1):3-4. 被引量:7
  • 2Alexakis C, Caruelle JP, Sezeur A, et al. Reversal of abnormal collagen production in Crohn' s disease intestinal biopsies treated with regenerating agents. Gut, 2004, 53 (1): 85-90.
  • 3Lawrance IC, Maxwell L, Doe W. Inflammation location, but not type, determines the increase in TGF-betal and IGF-1 expression and collagen deposition in IBD intestine. Inflamm Bowel Dis, 2001, 7 (1): 16-26.
  • 4Schmehl K, Florian S, Jacobasch G, et al. Deficiency of epithelial basement membrane laminin in ulcerative colitis affected human colonic mucosa. Int J Coloreetal Dis, 2000, 15 (1): 39-48.
  • 5Zilbemlan L, Maharshak N, Arbel Y, et al. Correlated expression of high-sensitivity C-reactive protein in relation to disease activity in inflammatory bowel disease: lack of differences between Crohn' s disease and ulcerative colitis. Digestion, 2006, 73 (4): 205-209.
  • 6Koutroubakis IE, Petinaki E, Dimoulios P, et al. Serum laminin and collagen Ⅳ in inflammatory bowel disease. J Clin Pathol, 2003, 56 (11): 817-820.
  • 7Kjeldsen J, Schaffalitzky de Muckadell OB, Junker P. Seromarkers of collagen Ⅰ and Ⅲ metabolism in active Crohn's disease. Relation to disease activity and response to therapy. Gut, 1995, 37 (6): 805-810.
  • 8Warnaar N, Hofker HS, Maathuis MH, et al. Matrix metalloproteinases as profibrotic factors in terminal ileum in Crohn's disease. Inflamm Bowel Dis, 2006, 12 (9): 863-869.

二级参考文献4

  • 1Levine AD, Fiocchi C. Immunology ofinflammatory bowel disease. Current Opinion in Gastroenterology, 2000, 16:306~309
  • 2Campieri M, Gionchetti P. Bacteria as the causeof ulcerative colitis. Gut, 2001,48: 132~135.
  • 3Dubinsky MC, Seidman EG. Diagnostic markersof inflammatory bowel disease. CurrentOpinionin Gastroenterology, 2000, 16: 337~342.
  • 4王怀鹏,马胜利,王宇琴,李世文.克隆病临床误诊16例分析[J].湖北医科大学学报,2000,21(3):220-221. 被引量:24

共引文献6

同被引文献25

  • 1巫协宁.克罗恩病和溃疡性结肠炎肠壁纤维化的发生机制[J].胃肠病学,2007,12(1):56-57. 被引量:5
  • 2姚希贤,徐克成.肝纤维化的基础和临床.第1版.上海:上海科技教育出版社,2003.
  • 3Latella G, Zanninelli G. Prevention and treatment of intestinal fibrosis:up regulate smad7 or inhibit smad3 counteract expression? Eur J Clin Invest, 2008, 38:878-880.
  • 4Mulsow JJ, Watson RW, Fitzpatrick JM, et al. Transforming growth factor-β promotes pro fihrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling. Ann Surg, 2005, 242: 880-889.
  • 5Li MH, Sanche T, Pappalardo A, et al. Induction of antiproliferative connective tissue growth factor expression in Wilms'tumor cells by sphingosine-1-phosphate receptor 2. Mol Cancer Res, 2008, 6: 1649-1656.
  • 6Karqer A, Fitzner B, Borck P, et al. Molecular insights into connective tissue growth factor action in rat pancreatic stellate cells. Cell Signal, 2008, 20:1865-1872.
  • 7Beddy D, Mulsow J, Watson RWG, et al. Expression and regulation of connective tissue growth factor by transforming growth factot β and turnout necrosis factor α in fibroblasts isolated from strictures in patients with Crohn's disease. Br J Surg, 2006, 93: 1290-1296.
  • 8Abraham DJ, Xu SW, Black CM,et al. Tumor necrosis factor a suppresses the induction of connective tissue growth factor by transforming growth factor-β in normal and scleroderma fibro blasts Vol. J Biol Chem, 2000, 20: 15220-15225.
  • 9Di Sabatino A, Ciccocioppo R, Benazzato L, et al. Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients. Aliment Phar macol Ther, 2004, 19: 1019-1024.
  • 10Pucilowska JB, McNaughton KK, Mohapatra NK, et al. IGF 1 and procollagen α ( Ⅰ ) are coexpressed in a subset of mesenchymal cells in active Crohn's disease. Am J Physiol Gastrointe st Liver Physiol, 2000, 279: G1307-1322.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部